Lori Anne Kunkel Sells 10,000 Shares of Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Lori Anne Kunkel sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $34.54, for a total transaction of $345,400.00. Following the completion of the sale, the director directly owned 51,884 shares of the company’s stock, valued at approximately $1,792,073.36. This represents a 16.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Trading Down 0.8%

Shares of Bitwise MARA Option Income Strategy ETF stock traded down $0.13 during midday trading on Tuesday, reaching $16.58. The company had a trading volume of 3,866 shares, compared to its average volume of 5,447. The company has a market capitalization of $3.15 million, a price-to-earnings ratio of 331.60 and a beta of 2.88. The stock has a fifty day simple moving average of $15.80 and a 200 day simple moving average of $15.97. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.